Terns Pharmaceuticals TERN
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 7.51 | 112.72 | -0.27 | -27,716 | -25 | |
| 2025Q2 | 3.73 | 113.96 | -0.26 | -27,383 | -24 | |
| 2025Q1 | 2.76 | 115.14 | -0.26 | -27,427 | -24 | |
| 2024Q4 | 5.54 | 119.26 | -0.23 | -25,949 | -22 | |
| 2024Q3 | 8.34 | 113.97 | -0.28 | -24,939 | -22 | |
| 2024Q2 | 6.81 | 112.62 | -0.31 | -25,537 | -23 | |
| 2024Q1 | 6.56 | 114.23 | -0.30 | -25,446 | -22 | |
| 2023Q4 | 6.49 | 114.73 | -0.29 | -24,058 | -21 | |
| 2023Q3 | 5.03 | 111.70 | -0.42 | -33,184 | -30 | |
| 2023Q2 | 8.75 | 118.71 | -0.25 | -21,159 | -18 | |
| 2023Q1 | 11.84 | 112.53 | -0.31 | -24,157 | -22 | |
| 2022Q4 | 10.18 | 108.54 | -0.17 | -16,828 | -16 | |
| 2022Q3 | 5.89 | 102.89 | -0.40 | -17,292 | -17 | |
| 2022Q2 | 2.48 | 101.15 | -0.55 | -14,084 | -14 | |
| 2022Q1 | 2.97 | 100.53 | -0.55 | -13,825 | -14 | |
| 2021Q4 | 7.07 | 100.47 | -0.57 | -13,878 | -14 | |
| 2021Q3 | 10.42 | 100.45 | -0.45 | -11,868 | -12 | |
| 2021Q2 | 12.26 | 100.88 | -0.31 | -10,818 | -11 | |
| 2021Q1 | 22.00 | 99.98 | -0.88 | -13,296 | -13 | |
| 2020Q4 | 95.12 | 8.45 | -8,768 | -10 |